| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pediatrics (R.W., S.E.T., C.W.Y., S.C.), Internal Medicine and Cellular and Molecular Physiology (G.C., G.I.S.), and Diagnostic Radiology and Biomedical Engineering (X.P.), General Clinical Research Center (W.V.T., J.D.), and Howard Hughes Medical Institute (S.D., G.I.S.), Yale University School of Medicine, New Haven, Connecticut 06520
Address all correspondence and requests for reprints to: Dr. Sonia Caprio, Department of Pediatrics, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208064, New Haven, Connecticut 06520. E-mail: sonia.caprio{at}yale.edu.
There is a wide interindividual variation in peripheral insulin sensitivity at any given body mass index or percent body fat among obese adolescents with normal glucose tolerance. The goals of this study were to determine whether variability in insulin sensitivity is associated with differences in patterns of lipid partitioning or substrate use under fasting and hyperinsulinemic conditions.
We compared 14 obese insulin-resistant adolescents with 14 obese insulin-sensitive controls, pair matched for age, gender, pubertal stage and body composition. Insulin sensitivity was assessed by the hyperinsulinemic-euglycemic clamp, intramyocellular lipid content by 1H-nuclear magnetic resonance and visceral fat by magnetic resonance imaging.
Obese insulin-sensitive subjects had lower intramyocellular (1.64 ± 0.68 vs.2.26 ± 0.62% of water peak, P = 0.017) and visceral lipid deposition (45 ± 23 vs. 77 ± 52 cm2, P = 0.04) and a higher level of adiponectin, compared with their obese-resistant counterparts (8.8 ± 3.6 vs. 6.5 ± 1.8 µg/dl, P = 0.015). Glycerol fluxes were similar between the two obese groups yet occurred in the face of different concentrations of insulin. Intramyocellular lipid and visceral fat were negatively related to insulin sensitivity.
Obese insulin-sensitive adolescents are characterized by lower lipid deposition in the intramyocellular and visceral compartments and greater levels of adiponectin, despite similar degree of adiposity.
This article has been cited by other articles:
 |
|
 |
|
  A. M. G. Cali and S. Caprio Obesity in Children and Adolescents J. Clin. Endocrinol. Metab., November 1, 2008; 93(11_Supplement_1): s31 - s36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R Desilets, S. Dhakal-Karki, and K. C Dunican Role of Metformin for Weight Management in Patients Without Type 2 Diabetes Ann. Pharmacother., June 1, 2008; 42(6): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. G. Cali', R. C. Bonadonna, M. Trombetta, R. Weiss, and S. Caprio Metabolic Abnormalities Underlying the Different Prediabetic Phenotypes in Obese Adolescents J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1767 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bouhours-Nouet, S. Dufresne, F. B. de Casson, E. Mathieu, O. Douay, F. Gatelais, S. Rouleau, and R. Coutant High Birth Weight and Early Postnatal Weight Gain Protect Obese Children and Adolescents From Truncal Adiposity and Insulin Resistance: Metabolically healthy but obese subjects? Diabetes Care, May 1, 2008; 31(5): 1031 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Yeckel, J. Dziura, and L. DiPietro Abdominal Obesity in Older Women: Potential Role for Disrupted Fatty Acid Reesterification in Insulin Resistance J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1285 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Weiss and F. R. Kaufman Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk Diabetes Care, February 1, 2008; 31(Supplement_2): S310 - S316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Weiss Fat distribution and storage: how much, where, and how? Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S39 - S45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Majuri, M Santaniemi, K Rautio, A Kunnari, J Vartiainen, A Ruokonen, Y A Kesaniemi, J S Tapanainen, O Ukkola, and L Morin-Papunen Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study Eur. J. Endocrinol., February 1, 2007; 156(2): 263 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Perseghin, R. Bonfanti, S. Magni, G. Lattuada, F. De Cobelli, T. Canu, A. Esposito, P. Scifo, G. Ntali, F. Costantino, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E697 - E703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bacha, R. Saad, N. Gungor, and S. A. Arslanian Are Obesity-Related Metabolic Risk Factors Modulated by the Degree of Insulin Resistance in Adolescents? Diabetes Care, July 1, 2006; 29(7): 1599 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Nadeau, L. B. Ehlers, L. E. Aguirre, R. L. Moore, K. N. Jew, H. K. Ortmeyer, B. C. Hansen, J. E. B. Reusch, and B. Draznin Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E90 - E98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srinivasan, G. R. Ambler, L. A. Baur, S. P. Garnett, M. Tepsa, F. Yap, G. M. Ward, and C. T. Cowell Randomized, Controlled Trial of Metformin for Obesity and Insulin Resistance in Children and Adolescents: Improvement in Body Composition and Fasting Insulin J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2074 - 2080. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
